Bladder and penile lesions with inguinal adenopathy after intravesical bacillus calmette-guerin (BCG) treatment

被引：5
|
作者：
Yates, Jennifer [1 ]
Stein, Barry [1 ]
机构：
[1] Brown Univ, Warren Alpert Sch Med, Dept Surg, Div Urol, Providence, RI 02905 USA
来源：
UROLOGY | 2007年 / 70卷 / 06期
关键词：
D O I：
10.1016/j.urology.2007.09.044
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Intravesical Bacillus Calmette-Guerin (BCG) is usually a well-tolerated treatment strategy for transitional cell cancer of the bladder. We report a patient with penile and bladder mucosal lesions with inguinal adenopathy after six instillations of intravesical BCG. Pathology demonstrated inflammation with granulomatous changes. The lesions and adenopathy resolved with antituberculous drug treatment. We describe the patient's clinical presentation and review the complications of intravesical BCG treatment.
引用
收藏
页码：1223.e15 / 1223.e17
页数：3
相关论文
共 50 条
  • [41] CANCER AND BCG (BACILLUS CALMETTE-GUERIN)
    RUMI, LS
    [J]. ACTA PHYSIOLOGICA LATINOAMERICANA, 1981, 31 (01) : 25 - 34
  • [42] The lipids of the bacillus Calmette-guerin (BCG).
    Chargaff, E
    [J]. HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1933, 217 : 115 - 137
  • [43] Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation
    Leebeek, FWG
    Ouwendijk, RJT
    Kolk, AHJ
    Dees, A
    Meek, JCE
    Nienhuis, JE
    DingemansDumas, AM
    [J]. GUT, 1996, 38 (04) : 616 - 618
  • [44] BACILLUS CALMETTE-GUERIN (BCG) ENDOPHTHALMITIS
    LESTER, H
    ERDEY, RA
    FASTENBERG, DM
    SCHWARTZ, PL
    ROSENHAUS, JB
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1988, 8 (03): : 182 - 184
  • [45] Local and systemic reactions after intravesical bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: The French experience.
    Blangy, H
    Loeuille, D
    Jouzeau, JY
    Ghiringhelli, CB
    Debois, H
    Netter, P
    Gillet, P
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S349 - S349
  • [46] SYSTEMIC BACILLUS CALMETTE-GUERIN INFECTION, BCGITIS, IN PATIENTS TREATED BY INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR BLADDER-CANCER
    STEG, A
    LELEU, C
    DEBRE, B
    BOCCONGIBOD, L
    SICARD, D
    [J]. EUROPEAN UROLOGY, 1989, 16 (03) : 161 - 164
  • [47] Spectrum of Bacille Calmette-Guerin (BCG) infection after intravesical BCG immunotherapy
    Gonzalez, OY
    Musher, DM
    Brar, I
    Furgeson, S
    Boktour, MR
    Septimus, EJ
    Hamill, RJ
    Graviss, EA
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) : 140 - 148
  • [48] MONITORING INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) TREATMENT OF SUPERFICIAL BLADDER-CARCINOMA BY SERIAL FLOW-CYTOMETRY
    BADALAMENT, RA
    GAY, H
    MELAMED, MR
    [J]. JOURNAL OF UROLOGY, 1986, 135 (04): : A288 - A288
  • [49] Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer
    Shepherd, Andrew R. H.
    Shepherd, Emily
    Brook, Nicholas R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [50] BLADDER EXPRESSION OF CYTOTOXIC EFFECTOR MOLECULES IN RESPONSE TO INTRAVESICAL MYCOBACTERIUM BOVIS BACILLUS CALMETTE-GUERIN (BCG)
    Knudson, Matthew
    Henning, Jonathan
    O'Donnell, Michael
    Luo, Yi
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E352 - E352
12345